sulbactam and Hypoxia
sulbactam has been researched along with Hypoxia in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Akat, H; Laloglu, F; Orbak, Z | 1 |
| Koch, A; Rohde, GG; Welte, T | 1 |
Trials
1 trial(s) available for sulbactam and Hypoxia
| Article | Year |
|---|---|
Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ampicillin; Bronchodilator Agents; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Hypoxia; Male; Middle Aged; Oxygen Inhalation Therapy; Prednisolone; Pulmonary Disease, Chronic Obstructive; Research Design; Sulbactam; Treatment Outcome | 2015 |
Other Studies
1 other study(ies) available for sulbactam and Hypoxia
| Article | Year |
|---|---|
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed | 2021 |